首页 > 市场调查报告书 > 製药

生物製药分析测试服务市场规模、份额和成长分析（按分子类型、测试类型、工作流程、应用、最终用户和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1897240

生物製药分析测试服务市场规模、份额和成长分析（按分子类型、测试类型、工作流程、应用、最终用户和地区划分）—2026-2033年产业预测

Biopharmaceutical Analytical Testing Services Market Size, Share, and Growth Analysis, By Molecule Type, By Test Type, By Workflow, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 249 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，生物製药分析测试服务市场规模将达到 85.7 亿美元，到 2025 年将达到 91.2 亿美元，到 2033 年将达到 149.3 亿美元，在预测期（2026-2033 年）内，复合年增长率为 6.36%。

生物製药分析检测服务市场对于治疗性蛋白质和化合物的成功开发至关重要。先进的分析方法在药物发现的整个过程中提供重要的分子信息，包括申报监测、生物工艺优化和药物释放测试。随着生物治疗药物日益复杂，先进的分析技术对于阐明其结构和活性以及识别杂质的至关重要。随着生物製药研发的扩展，越来越多的分析工具涌现，提高了检测具有治疗潜力的潜在药物标靶的能力。生命科学产业在疫情后復苏，进一步刺激了对这些关键服务的需求，巩固了北美及其他地区的市场成长前景。

生物製药分析测试服务市场按分子类型、测试类型、工作流程、应用领域、最终用户和地区进行细分。依分子类型划分，市场分为小分子和大分子。依测试类型划分，市场分为ADME（吸收、分布、代谢和排泄）、药物动力学（PK）、动态（PD）、生物利用度、生物等效性及其他。依工作流程划分，市场分为样品製备与样品分析。依应用领域划分，市场分为肿瘤学、神经病学、心臟病学、感染疾病及其他。按最终用户划分，市场分为製药和生物技术公司、受託研究机构（CRO）、学术和研究机构及其他。依地区划分，市场分为北美、欧洲、亚太、拉丁美洲以及中东和非洲。

生物製药分析测试服务市场的成长要素

推动生物製药分析检测服务业成长的关键因素之一是丙烯腈-甲基丙烯酸甲酯-丁二烯苯乙烯（AMMBS）需求的不断增长。这一增长主要归因于丙烯腈-甲基丙烯酸甲酯全球市场的扩张，该材料在免疫疗法中发挥关键作用，能够增强身体对多种疾病的免疫反应。针对类风湿性关节炎和癌症等疾病的抗体研发投入也不断增加。此外，癌症治疗领域的创新方法包括精准肿瘤靶向，从而实现更有效的治疗。对这些特殊疗法的日益关注，也推动了生物製药产业对分析检测服务需求的成长。

生物製药分析测试服务市场的限制因素

测试和分析不足可能导致产品因未能达到必要的监管标准而出现严重缺陷。如果产品不符合这些基本要求，公司可能会遭受重大经济损失，并且可能难以重新启动或重新评估其药物测试流程。这种限制不仅阻碍了公司将有效疗法推向市场的能力，而且还会威胁到公司的声誉和业务永续营运。因此，分析测试服务不足带来的风险是限制生物製药分析测试服务市场成长的一大阻碍因素。

生物製药分析测试服务市场趋势

生物製药分析检测服务市场呈现强劲的上升趋势，这主要得益于研发投入的不断成长，尤其是在新兴经济体。推动这一成长势头的，是对先进检测解决方案日益增长的需求，以确保生物製药产品的有效性和安全性。随着开发中国家不断加强实验室基础设施和研发能力，分析检测领域的服务供应商迎来了新的机会。此外，监管审查的日益严格以及对创新治疗方法需求的增长，进一步推高了对专业检测服务的需求，从而巩固了市场的成长势头。

北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Eurofins Scientific
Charles River Laboratories
WuXi AppTec
SGS SA
Laboratory Corporation of America Holdings（LabCorp）
IQVIA
Medpace
Intertek Group
Syneos Health
ICON plc
Frontage Laboratories
PPD（Pharmaceutical Product Development）
PAREXEL International
Almac Group
Celerion
Altasciences
BioAgilytix Labs
Lotus Labs
LGS Limited
Sartorius AG

结论与建议

简介目录

Product Code: SQMIG35H2168

Biopharmaceutical Analytical Testing Services Market size was valued at USD 8.57 Billion in 2024 and is poised to grow from USD 9.12 Billion in 2025 to USD 14.93 Billion by 2033, growing at a CAGR of 6.36% during the forecast period (2026-2033).

The biopharmaceutical analytical testing services market is pivotal for the successful development of therapeutic proteins and compounds. Advanced analytical methods provide essential molecular insights that inform the entire drug discovery process, encompassing applicant monitoring, bioprocess optimization, and drug release testing. The increasing complexity of biotherapeutics necessitates sophisticated analytical technologies to elucidate their structures and activities, as well as identify impurities. As research and development in biopharmaceuticals expand, a diverse array of analytical tools continues to emerge, enhancing the detection of promising drug targets with significant therapeutic potential. The revival of life sciences operations following disruptions has further stimulated demand for these vital services, solidifying the market's growth prospects in North America and beyond.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biopharmaceutical Analytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biopharmaceutical Analytical Testing Services Market Segments Analysis

Biopharmaceutical Analytical Testing Services Market is segmented by molecule type, test type, workflow, application, end user and region. Based on molecule type, the market is segmented into small molecule and large molecule. Based on test type, the market is segmented into ADME (absorption, distribution, metabolism, and excretion), pharmacokinetics (PK), pharmacodynamics (PD), bioavailability, bioequivalence and others. Based on workflow, the market is segmented into sample preparation and sample analysis. Based on application, the market is segmented into oncology, neurology, cardiology, infectious diseases and others. Based on end users, the market is segmented into pharmaceutical and biotechnology companies,contract research organizations (CROs), academic and research institutes and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biopharmaceutical Analytical Testing Services Market

A significant driver of growth in the biopharmaceutical analytical testing services sector is the escalating demand for Methyl Methacrylate Acrylonitrile Butadiene Styrene. This surge is attributed to the global market's expansion for acrylonitrile methyl methacrylate, which plays a crucial role in immunotherapy by enhancing immune responses for various diseases. Research and development efforts focused on antibodies targeting conditions such as rheumatoid arthritis and cancer are increasing. Furthermore, innovative approaches in cancer treatment involve precise targeting of tumors, thereby facilitating more effective therapies. This enhanced focus on specialized treatments underscores the rising need for analytical testing services in the biopharmaceutical industry.

Restraints in the Biopharmaceutical Analytical Testing Services Market

Inadequate testing and analysis can result in significant product failures, as they may not align with the necessary regulatory standards. When products do not fulfill these essential requirements, companies face substantial financial losses and may find it challenging to resume or reassess their drug testing processes. This limitation not only hinders a company's ability to bring effective treatments to market but also jeopardizes its reputation and operational viability. As a result, the risk associated with improper analytical testing services poses a notable restraint on the growth of the biopharmaceutical analytical testing services market.

Market Trends of the Biopharmaceutical Analytical Testing Services Market

The biopharmaceutical analytical testing services market is witnessing a robust upward trend fueled by heightened investments in research and development, particularly in emerging economies. This momentum is being driven by the growing necessity for advanced testing solutions to ensure the efficacy and safety of biopharmaceutical products. As developing nations ramp up their laboratory infrastructures and research capabilities, they are creating new opportunities for service providers in the analytical testing sector. Additionally, increased regulatory scrutiny and the demand for innovative therapies are propelling the need for specialized testing services, further solidifying the market's growth trajectory.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis

Global Biopharmaceutical Analytical Testing Services Market Size by Molecule Type & CAGR (2026-2033)

Market Overview
Small Molecule
Large Molecule

Global Biopharmaceutical Analytical Testing Services Market Size by Test Type & CAGR (2026-2033)

Market Overview
ADME (Absorption, Distribution, Metabolism, and Excretion)
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Bioavailability
Bioequivalence
Others

Global Biopharmaceutical Analytical Testing Services Market Size by Workflow & CAGR (2026-2033)

Market Overview
Sample Preparation
Sample Analysis

Global Biopharmaceutical Analytical Testing Services Market Size by Application & CAGR (2026-2033)

Market Overview
Oncology
Neurology
Cardiology
Infectious Diseases
Others

Global Biopharmaceutical Analytical Testing Services Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Academic and Research Institutes
Others

Global Biopharmaceutical Analytical Testing Services Market Size & CAGR (2026-2033)

North America (Molecule Type, Test Type, Workflow, Application, End User)
- US
- Canada
Europe (Molecule Type, Test Type, Workflow, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific (Molecule Type, Test Type, Workflow, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America (Molecule Type, Test Type, Workflow, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Molecule Type, Test Type, Workflow, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Eurofins Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (LabCorp)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IQVIA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medpace
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Frontage Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PPD (Pharmaceutical Product Development)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PAREXEL International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celerion
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altasciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioAgilytix Labs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lotus Labs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGS Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments